Global Sodium Iodide I-131 Kits and Capsules Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Sodium Iodide I-131 Kits and Capsules market size will reach US$ 639 million by 2031.
Sodium Iodide I-131 is a radioactive isotope of iodine used for diagnostic imaging and therapeutic nuclear medicine applications, primarily targeting the thyroid gland. It exploits the fact that the thyroid avidly absorbs iodine to deliver precise radioactive treatment or imaging contrast.
Cancer is the second leading cause of death in the world, and its number of deaths and cases is increasing year by year. At the same time, based on the unparalleled advantages of nuclear medicine in precision treatment and integrated tumor diagnosis and treatment, the demand for radionuclide drugs and nuclear medicine examinations is expected to increase year by year. The demand for sodium iodide [131I] capsules and solutions has also increased, mainly including diseases such as thyroid tumors and hyperthyroidism.
Governments in many countries are encouraging and supporting innovation and development in the medical industry, including research on nuclear medicine and radiopharmaceuticals, which provides policy support for the development of the sodium iodide [131I] capsule and solution market.
With the advancement of research and development and production technology of radiopharmaceuticals, more effective and safer sodium iodide [131I] capsules and solutions have been produced, thus promoting the development of the industry.
The use of radiopharmaceuticals is subject to strict regulations and supervision. Failure to comply with regulations may lead to product recalls or market access barriers, thus affecting market development.
The public's understanding of radiopharmaceuticals is insufficient, and some patients may have doubts or concerns about radiotherapy, which may affect the market demand for sodium iodide I-131 drugs.
The safety of radiopharmaceuticals is a key factor in the development of the market, and any safety accidents or leaks may have a negative impact on the industry's image and the market.
With the continuous advancement of science and technology, new production technologies and processes will be introduced into the industry. These new technologies can improve product quality, increase production efficiency, and reduce costs.
Many countries are reforming their healthcare systems to provide better medical services and more effective treatments. This reform is expected to promote the use of sodium iodide [131I] capsules and solutions and bring more opportunities to the industry.
Global cooperation and competition will have an impact on the development of the industry. Cooperation between manufacturers, suppliers, and research institutions in different countries and regions helps promote technological innovation and market expansion, but there is also fierce competition.
LPI (LP Information)' newest research report, the “Sodium Iodide I-131 Kits and Capsules Industry Forecast” looks at past sales and reviews total world Sodium Iodide I-131 Kits and Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Sodium Iodide I-131 Kits and Capsules sales for 2025 through 2031. With Sodium Iodide I-131 Kits and Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide I-131 Kits and Capsules industry.
This Insight Report provides a comprehensive analysis of the global Sodium Iodide I-131 Kits and Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sodium Iodide I-131 Kits and Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Iodide I-131 Kits and Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide I-131 Kits and Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide I-131 Kits and Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide I-131 Kits and Capsules market by product type, application, key players and key regions and countries.
Segmentation by Type:
Capsule
Solution
Segmentation by Application:
Hyperthyroidism Treatment
Thyroid Cancer Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
International Isotopes Inc
CNNC
DC Pharma
Curium Pharma
Jubilant Pharmova
PDRadiopharma
ANSTO
POLATOM（NCBJ）
NTP Radioisotopes
Isotope JSC (Rosatom)
Institute of Isotopes Co. Ltd.
JRTR
Please note: The report will take approximately 2 business days to prepare and deliver.
Sodium Iodide I-131 is a radioactive isotope of iodine used for diagnostic imaging and therapeutic nuclear medicine applications, primarily targeting the thyroid gland. It exploits the fact that the thyroid avidly absorbs iodine to deliver precise radioactive treatment or imaging contrast.
Cancer is the second leading cause of death in the world, and its number of deaths and cases is increasing year by year. At the same time, based on the unparalleled advantages of nuclear medicine in precision treatment and integrated tumor diagnosis and treatment, the demand for radionuclide drugs and nuclear medicine examinations is expected to increase year by year. The demand for sodium iodide [131I] capsules and solutions has also increased, mainly including diseases such as thyroid tumors and hyperthyroidism.
Governments in many countries are encouraging and supporting innovation and development in the medical industry, including research on nuclear medicine and radiopharmaceuticals, which provides policy support for the development of the sodium iodide [131I] capsule and solution market.
With the advancement of research and development and production technology of radiopharmaceuticals, more effective and safer sodium iodide [131I] capsules and solutions have been produced, thus promoting the development of the industry.
The use of radiopharmaceuticals is subject to strict regulations and supervision. Failure to comply with regulations may lead to product recalls or market access barriers, thus affecting market development.
The public's understanding of radiopharmaceuticals is insufficient, and some patients may have doubts or concerns about radiotherapy, which may affect the market demand for sodium iodide I-131 drugs.
The safety of radiopharmaceuticals is a key factor in the development of the market, and any safety accidents or leaks may have a negative impact on the industry's image and the market.
With the continuous advancement of science and technology, new production technologies and processes will be introduced into the industry. These new technologies can improve product quality, increase production efficiency, and reduce costs.
Many countries are reforming their healthcare systems to provide better medical services and more effective treatments. This reform is expected to promote the use of sodium iodide [131I] capsules and solutions and bring more opportunities to the industry.
Global cooperation and competition will have an impact on the development of the industry. Cooperation between manufacturers, suppliers, and research institutions in different countries and regions helps promote technological innovation and market expansion, but there is also fierce competition.
LPI (LP Information)' newest research report, the “Sodium Iodide I-131 Kits and Capsules Industry Forecast” looks at past sales and reviews total world Sodium Iodide I-131 Kits and Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Sodium Iodide I-131 Kits and Capsules sales for 2025 through 2031. With Sodium Iodide I-131 Kits and Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide I-131 Kits and Capsules industry.
This Insight Report provides a comprehensive analysis of the global Sodium Iodide I-131 Kits and Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sodium Iodide I-131 Kits and Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Iodide I-131 Kits and Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide I-131 Kits and Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide I-131 Kits and Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide I-131 Kits and Capsules market by product type, application, key players and key regions and countries.
Segmentation by Type:
Capsule
Solution
Segmentation by Application:
Hyperthyroidism Treatment
Thyroid Cancer Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
International Isotopes Inc
CNNC
DC Pharma
Curium Pharma
Jubilant Pharmova
PDRadiopharma
ANSTO
POLATOM（NCBJ）
NTP Radioisotopes
Isotope JSC (Rosatom)
Institute of Isotopes Co. Ltd.
JRTR
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
114 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Sodium Iodide I-131 Kits and Capsules Market Size by Player
- 4 Sodium Iodide I-131 Kits and Capsules by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Sodium Iodide I-131 Kits and Capsules Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
